Genotypic Resistance of Antiretroviral Drugs among Drug-Naive HIV Type 1 Patients with the Background of Long-Term Access-Easy Zidovudine Therapy

AIDS Research and Human Retroviruses

Volumn 19, Issue 11, 2003, Pages 1039-1043

  Park, Sang Won ^a,b   Kim, Hong Bin ^a   Choi, Young Ju ^a   Kim, Nam Jung ^a   Oh, Myoung Don ^a   Choe, Kang Won ^a,c  

^a Seoul National University College of Medicine   (South Korea)

^b Dankook University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROTEINASE; RNA; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADULT; AGED; ASIA; BLOOD SAMPLING; CODON; CONTROLLED STUDY; DRUG SENSITIVITY; EPIDEMIOLOGICAL DATA; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KOREA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; VIRUS MUTATION;

ADULT; AGED; ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; KOREA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PREVALENCE; REVERSE TRANSCRIPTASE INHIBITORS; SEQUENCE ANALYSIS, DNA; TIME FACTORS; ZIDOVUDINE;

EID: 0345688744     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203322588404     Document Type: Review

References (21)

1. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, and Leibowitch J: Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-116.
2. Lederman MM, Connick E, Landay A, Kuritzkes DR, Spritzler J, St Clair M, Kotzin BL, Fox L, Chiozzi MH, Leonard JM, Rousseau F, Wade M, Roe JD, Martinez A, and Kessler H: Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: Results of AIDS Clinical Trials Group protocol 315. J Infect Dis 1998;178:70-79.
3. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, and Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-860.
4. Murphy EL, Collier AC, Kalish LA, Assmann SF, Para MF, Flanigan TP, Kumar PN, Mintz L, Wallach FR, and Nemo GJ: Highly active retroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 2001;135: 17-26.
5. Erice A, Mayers DL, Strike DG, Sannerud KJ, McCutchan FE, Henry K, and Balfour HH Jr: Primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Engl J Med 1993;328:1163-1165.
6. Imrie A, Beveridge A, Genn W, Vizzard J, and Cooper DA: Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. J Infect Dis 1997;175:1502-1506.
7. Conlon CP, Klenerman P, Edwards A, Larder BA, and Philips RE: Heterosexual transmission of human immunodeficiency virus type 1 variants associated with zidovudine resistance. J Infect Dis 1994;169:411-415.
8. de Ronde A, Schuurman R, Goudsmit J, van den Hoek A, and Boucher C: First case of new infection with zidovudine-resistant HIV-1 among prospectively studied intravenous drug users and homosexual men in Amsterdam, the Netherlands. AIDS 1996;10: 231-232.
9. Fitzgibbon JE, Gaur S, Frenkel LD, Laraque F, Edlin BR. and Dubin DT: Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation. N Engl J Med 1993;329:1835-1841.
10. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collir AC, Koup RA, Mellors JW, Connick E, Conway B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, and Richman DD: Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002;347:385-394.
11. Wainberg MA and Friedland G: Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 1998;279: 1977-1983.
12. Lee SH, Kim NJ, Kim US, Bang JH, Kim T, Oh MD, and Choe KW: The effect of combination therapy of zidovudine, lamivudine, and indinavir in HIV infected patients. Korean J Infect Dis 2001;33:46-51.
13. Perez EE, Rose SL, Peyser B, Lamers SL, Burkhardt B, Dunn BM, Hutson AD, Sleasman JW, and Goodenow MM: Human immunodeficiency virus type 1 protease genotype predicts immune and viral response to combination therapy with protease inhibitors (PIs) in PI-naive patients. J Infect Dis 2001;183:579-588.
14. Hirsch MS, Brun-Vezinet F, D'Aquila RT, Hammer SM, Johnson VA, Kuritzkes DR, Loveday C, Mellors JW, Clotet B, Conway B, Demeter LM, Vella S, Jacobsen DM, and Richman DD: Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an International AIDS Society-USA panel. JAMA 2000;283:2417-2426.
15. Kim J: HIV resistance and genotypic characteristics. In: A Study on Emerging Infectious Diseases in Korea - Korea Health 21 R&D project (HMP-99-M-04-0002). Ministry of Health and Welfare, Seoul, 2002, pp. 224-234.
16. Yerly S, Vora S, Rizzardi P, Chave JP, Vernazza PL, Flepp M, Telenti A, Battegay M, Veuthey AL, Bru JP, Rickenbach M, Hirschel B, and Perrin L: Acute HIV infection: Impact on the spread of HIV and transmission of drug resistance. AIDS 2001;15: 2287-2292.
17. Balotta C, Berlusconi A, Pan A, Violin M, Riva C, Colombo MC, Gori A, Papagno L, Corvasce S, Mazzucchelli R, Facchi G, Velleca R, Saporetti G, Galli M, Rusconi S, and Moroni M: Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and pretease region: Outcome after treatment in recently infected individuals. Antiviral Ther 2000;5:7-14.
18. UK Collaborative Group on Monitoring the Transmission of HIV Drug Resistance: Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom. BMJ 2001;322: 1087-1088.
19. Mayers DL: Prevalence and clinical course of persons seroconverting with AZT-resistant HIV-1 in Switzerland, Australia, and the United States between 1988 and 1994. AIDS Res Hum Retroviruses 1995;11(Suppl. 1):S162.
20. Rubio A, Leal M, Pineda JA, Caruz A, Luque F, Rey C, Sanchez-Quijano A, and Lissen E: Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1 infected antiviral-naive patients from 1989 to 1996. AIDS 1997;11: 1184-1186.
21. Youn BB, Kang HC, Oh YW, and Lee CY: A case report of acquired immune deficiency syndrome with multiple problems, such as fever, dyspnea, abdominal pain, oral candidiasis, candida albicans esophagitis & etc. New Med J 1985;28:913-922.